MBX · MBX Biosciences, Inc. · Documents
$52.97
+2.68 (+5.33%)
At close · Oct 27
Return incl. dividend (before tax)
Q2 2025 earnings call transcript
Market Cap
$2.42B
Shares
48.16M
Volume · Oct 27
493.02K
Avg daily vol (3M)
521.8K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | MBX Biosciences appointed Peter Radovich as an independent director and set the board at eight directors. His initial compensation includes a non-qualified stock option for 18,200 shares. | 2026-10-22 | 2026-10-20 | |
| Investor Event Transcript | — | 2026-09-16 | 2026-09-30 | |
| 8-K | — | 2026-08-27 | — | |
| 8-K | — | 2026-08-06 | — | |
| 10-Q | — | 2026-08-06 | 2026-06-30 | |
| 8-K | — | 2026-07-13 | 2026-07-09 | |
| 8-K | — | 2026-06-12 | — | |
| Investor Event Transcript | — | 2026-06-12 | 2026-06-30 | |
| 8-K | — | 2026-06-05 | 2026-06-04 | |
| Investor Event Transcript | — | 2026-06-03 | 2026-06-30 | |
| 8-K | — | 2026-05-11 | — | |
| DEFA14A | — | 2026-05-08 | — | |
| 8-K | — | 2026-05-07 | — | |
| 10-Q | — | 2026-05-07 | 2026-03-31 | |
| ARS | — | 2026-04-22 | 2025-12-31 | |
| DEF 14A | — | 2026-04-22 | — | |
| DEFA14A | — | 2026-04-22 | — | |
| 8-K | — | 2026-03-12 | — | |
| 10-K | — | 2026-03-12 | 2025-12-31 | |
| S-3ASR | — | 2026-03-12 | — | |
| Investor Event Transcript | — | 2026-03-11 | 2026-03-31 | |
| 8-K | — | 2026-03-09 | — | |
| 8-K | — | 2026-02-27 | 2026-02-24 | |
| 8-K | — | 2026-02-05 | 2026-02-04 | |
| 8-K | — | 2026-01-22 | 2026-01-20 | |
| 8-K | — | 2026-01-12 | 2026-01-11 | |
| 10-Q | — | 2025-11-06 | 2025-09-30 | |
| 8-K | — | 2025-11-06 | 2025-10-31 | |
| S-3 | — | 2025-11-06 | — | |
| Investor Event Transcript | — | 2025-09-30 | — | |
| 8-K | — | 2025-09-26 | 2025-09-24 | |
| 8-K | — | 2025-09-22 | — | |
| S-1 | — | 2025-09-22 | — | |
| 8-K | — | 2025-09-04 | — | |
| 8-K | — | 2025-08-07 | — | |
| 10-Q | — | 2025-08-07 | 2025-06-30 | |
| 8-K | — | 2025-06-16 | — | |
| 8-K | — | 2025-06-09 | — | |
| 8-K | — | 2025-06-06 | 2025-06-05 | |
| 10-Q | — | 2025-05-12 | 2025-03-31 | |
| 8-K | — | 2025-05-12 | — | |
| ARS | — | 2025-04-23 | 2024-12-31 | |
| DEFA14A | — | 2025-04-23 | — | |
| DEF 14A | — | 2025-04-23 | 2025-04-22 | |
| 8-K | — | 2025-04-07 | — | |
| 8-K | — | 2025-03-17 | — | |
| 10-K | — | 2025-03-17 | 2024-12-31 | |
| 8-K | — | 2025-01-07 | — | |
| 8-K | — | 2024-11-07 | — | |
| 10-Q | — | 2024-11-07 | 2024-09-30 |
Showing 1–50 of 54 filings
Key facts
CIK
1776111
CUSIP
55287L101
13F (30d)
21 filings
21 filers
Visit website
Investor relations